3965 Original Article The clinical value of 18F-fluoroestradiol in assisting individualized treatment decision in dual primary malignancies Ziyi Yang1,2,3#, Yizhao Xie4,5#, Cheng Liu1,2,3, Xin Liu4,5, Shaoli Song1,2,3, Yingjian Zhang1,2,3, Rui Ge6, Biyun Wang4,5, Zhongyi Yang1,2,3 1Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China; 2Center for Biomedical Imaging, Fudan University, Shanghai, China; 3Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China; 4Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; 5Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 6Department of General Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China Contributions: (I) Conception and design: Z Yang, Y Xie, R Ge, B Wang, Z Yang; (II) Administrative support: S Song, Y Zhang; (III) Provision of study materials or patients: Z Yang, Y Xie, Z Yang; (IV) Collection and assembly of data: Z Yang, Y Xie, Z Yang; (V) Data analysis and interpretation: Z Yang, Y Xie, C Liu, X Liu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Rui Ge. Department of General Surgery, Huadong Hospital Affiliated to Fudan University, 221 West Yan’an Road, Jingan District Shanghai 200040, China. Email:
[email protected]; Biyun Wang. Department of Medical Oncology, Fudan University Shanghai Cancer Center, No. 270 Dong’an Road, Xuhui District, Shanghai 200032, China. Email:
[email protected]; Zhongyi Yang. Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, No. 270 Dong’an Road, Xuhui District, Shanghai 200032, China.